This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nitto Denko Avecia, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Huihe Zhu: Innovator in Oligonucleotide Manufacturing
Introduction
Huihe Zhu is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of oligonucleotide manufacturing, showcasing his expertise through his innovative patent.
Latest Patents
Huihe Zhu holds a patent titled "Process for the manufacture of oligonucleotides." This patent describes a process for manufacturing an oligonucleotide that involves removing β-eliminating phosphorus-protecting groups, particularly β-cyanoethyl protective groups from a protected oligonucleotide. The process includes contacting the protected oligonucleotide with an amine solution in a solvent that preferably does not consist of pyridine. The conjugate acid of the amine has a pKa of greater than 11.5, and the concentration of the amine in the solution is less than 0.5 mole/liters. This innovative approach enhances the efficiency of oligonucleotide production.
Career Highlights
Huihe Zhu is currently employed at Nitto Denko Avecia, Inc., where he continues to develop and refine processes related to oligonucleotide manufacturing. His work has positioned him as a key player in the biotechnology sector, contributing to advancements in genetic research and therapeutic applications.
Collaborations
Huihe Zhu has collaborated with notable colleagues, including Tadeusz Krzysztof Wyrzykiewicz and Hagen Cramer. These collaborations have fostered a productive environment for innovation and research within the company.
Conclusion
Huihe Zhu's contributions to the field of oligonucleotide manufacturing through his patent and work at Nitto Denko Avecia, Inc. highlight his role as an influential inventor. His innovative processes are paving the way for advancements in biotechnology and genetic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile